The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines

BMC Infectious Diseases

Table 2 Maternal poliovirus type-specific antibody levels of the study participants

Group	N	Type	Positive participants	Positive rate (%)	GMT	Participants with different titers (1:)
Group	N	Type	Positive participants	Positive rate (%)	GMT	< 8	8 ~ < 32	≥32
1	109	I	82	75.23	17.57	27	47	35
		II	49	44.95	8.39	60	33	16
		III	29	26.61	6.13	80	20	9
2	125	I	98	78.40	18.44	27	50	48
		II	43	34.40	6.73	82	30	13
		III	23	18.40	5.33	102	19	4
3	127	I	90	70.87	17.99	37	39	51
		II	46	36.22	6.69	81	35	11
		III	21	16.54	5.59	106	14	7
4	124	I	96	77.42	21.21	28	40	56
		II	47	37.90	6.44	77	42	5
		III	33	26.61	6.41	91	23	10
5	124	I	95	76.61	19.15	29	45	50
		II	46	37.10	6.92	78	36	10
		III	31	25.00	5.79	93	25	6

Group 1: low-dose Sabin IPV group. Group 2: medium-dose Sabin IPV group. Group 3: high-dose Sabin IPV group. Group 4: control Sabin IPV group. Group 5: control Salk IPV group

ISSN: 1471-2334